Cardiovascular Disease Doctors in Powell, TN Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

Dr. Kyle Mccoy, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

Dr. David Allan Cox, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

Dr. Charles B Treasure Ii, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

Keith Aaron Kyker, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

Dr. John Andrew Ternay, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

Dr. Russell Rotondo, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7557b Dannaher Dr Ste 225, Powell, TN 37849 Phone: 865-647-5800    Fax: 865-647-5979

News Archive

One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented

If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among under 3s could be reduced by a third, and deaths by up to a quarter, according to new research being published today.

Antidepressant use during pregnancy not linked to newborn problems at 2-4 weeks after birth

Babies exposed to an antidepressant or a mood disorder during fetal life did not have any more signs of irritability, difficulty feeding, sleep disturbances and respiratory problems two to four weeks after birth than babies who were not exposed.

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC-NCI-AACR

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.

The association of registered nurse staffing levels and patient outcomes

If hospitals added one more full-time registered nurse on staff to care for patients, the number of hospital-related deaths in the United States could decrease significantly, according to a new review.

Read more Medical News

› Verified 1 days ago